Association between per- and polyfluoroalkyl substances and risk of hypertension: a systematic review and meta-analysis

Existing evidence indicates that exposure to per- and polyfluoroalkyl substances (PFASs) may increase the risk of hypertension, but the findings are inconsistent. Therefore, we aimed to explore the relationship between PFASs and hypertension through this systematic review and meta-analysis.We searched PubMed, Embase, and the Web of Science databases for articles published in English that examined the relationship between PFASs and hypertension before 13 August 2022. The random effects model was used to aggregate the evaluation using Stata 15.0 for Windows. We also conducted subgroup analyses by region and hypertension definition. In addition, a sensitivity analysis was carried out to determine the robustness of the findings.The meta-analysis comprised 15 studies in total with 69,949 individuals. The risk of hypertension was substantially and positively correlated with exposure to perfluorooctane sulfonate (PFOS) (OR = 1.31, 95% CI: 1.14, 1.51), perfluorooctanoic acid (PFOA) (OR = 1.16, 95% CI: 1.07, 1.26), and perfluorohexane sulfonate (PFHxS) (OR = 1.04, 95% CI: 1.00, 1.09). However, perfluorononanoic acid (PFNA) exposure and hypertension were not significantly associated (OR = 1.08, 95% CI: 0.99, 1.17).We evaluated the link between PFASs exposure and hypertension and discovered that higher levels of PFOS, PFOA, and PFHxS were correlated with an increased risk of hypertension. However, further high-quality population-based and pathophysiological investigations are required to shed light on the possible mechanism and demonstrate causation because of the considerable variability.https://www.crd.york.ac.uk/prospero/ PROSPERO, registration number: CRD 42022358142.

[1]  C. Ward‐Caviness,et al.  Associations between PFAS occurrence and multimorbidity as observed in an electronic health record cohort , 2022, Environmental epidemiology.

[2]  A. Calafat,et al.  Per- and Polyfluoroalkyl Substances and Incident Hypertension in Multi-Racial/Ethnic Women: The Study of Women's Health Across the Nation , 2022, Hypertension.

[3]  Qun Xu,et al.  Novel Strategies for Assessing Associations Between Selenium Biomarkers and Cardiometabolic Risk Factors: Concentration, Visit-to-Visit Variability, or Individual Mean? Evidence From a Repeated-Measures Study of Older Adults With High Selenium , 2022, Frontiers in Nutrition.

[4]  J Zhang,et al.  Association between per- and polyfluoroalkyl substances and risk of gestational diabetes mellitus. , 2021, International journal of hygiene and environmental health.

[5]  Kai Li,et al.  The association of arsenic exposure with hypertension and blood pressure: A systematic review and dose-response meta-analysis. , 2021, Environmental pollution.

[6]  M. Bloom,et al.  Perfluorooctane sulfonate alternatives and metabolic syndrome in adults: New evidence from the Isomers of C8 Health Project in China. , 2021, Environmental pollution.

[7]  T. Fletcher,et al.  Associations of Perfluoroalkyl Substances with Prevalence of Metabolic Syndrome in Highly Exposed Young Adult Community Residents—A Cross-Sectional Study in Veneto Region, Italy , 2021, International journal of environmental research and public health.

[8]  A. Furberg,et al.  Exposure to perfluoroalkyl substances (PFAS) and dyslipidemia, hypertension and obesity in adolescents. The Fit Futures study. , 2021, Environmental research.

[9]  S. Fenton,et al.  Early life exposure to per- and polyfluoroalkyl substances (PFAS) and latent health outcomes: A review including the placenta as a target tissue and possible driver of peri- and postnatal effects. , 2020, Toxicology.

[10]  Weiping Liu,et al.  Exposure characteristics for congeners, isomers, and enantiomers of perfluoroalkyl substances in mothers and infants. , 2020, Environment international.

[11]  T. Fletcher,et al.  Perfluoroalkyl substances are associated with elevated blood pressure and hypertension in highly exposed young adults , 2020, Environmental Health.

[12]  Mohammed Zeeshan,et al.  Serum levels of per- and polyfluoroalkyl substances alternatives and blood pressure by sex status: Isomers of C8 health project in China. , 2020, Chemosphere.

[13]  Ting Yin,et al.  Association between perfluoroalkyl acids and the prevalence of hypertension among US adults. , 2020, Ecotoxicology and environmental safety.

[14]  K. Kleinman,et al.  Per- and polyfluoroalkyl substances and blood pressure in pre-diabetic adults-cross-sectional and longitudinal analyses of the diabetes prevention program outcomes study. , 2020, Environment international.

[15]  Yuming Guo,et al.  Long-term exposure to airborne particulate matter of 1 μm or less and blood pressure in healthy young adults: A national study with 1.2 million pregnancy planners. , 2020, Environmental research.

[16]  P. Rudan,et al.  Association of perfluoroalkyl substances exposure with cardiometabolic traits in an island population of the eastern Adriatic coast of Croatia. , 2019, The Science of the total environment.

[17]  K. Kleinman,et al.  Per- and polyfluoroalkyl substances and blood lipid levels in pre-diabetic adults-longitudinal analysis of the diabetes prevention program outcomes study. , 2019, Environment international.

[18]  Andrew A. Rooney,et al.  GRADE guidelines for environmental and occupational health: A new series of articles in Environment International , 2019, Environment international.

[19]  Yuming Guo,et al.  Ambient PM1 air pollution, blood pressure, and hypertension: Insights from the 33 Communities Chinese Health Study , 2019, Environmental research.

[20]  J. Sommar,et al.  Associations between repeated measure of plasma perfluoroalkyl substances and cardiometabolic risk factors. , 2019, Environment international.

[21]  Xinyu Chen,et al.  Serum polyfluoroalkyl chemicals are associated with risk of cardiovascular diseases in national US population. , 2018, Environment international.

[22]  G. Lip,et al.  2018 ESC/ESH Guidelines for the management of arterial hypertension. , 2018, European heart journal.

[23]  Z. Qian,et al.  Gender-specific associations between serum isomers of perfluoroalkyl substances and blood pressure among Chinese: Isomers of C8 Health Project in China. , 2017, The Science of the total environment.

[24]  L. McCandless,et al.  Gestational exposure to endocrine disrupting chemicals in relation to infant birth weight: a Bayesian analysis of the HOME Study , 2017, Environmental Health.

[25]  G. Gambaro,et al.  Dietary and Lifestyle Risk Factors Associated with Incident Kidney Stones in Men and Women , 2017, The Journal of urology.

[26]  A. Moran,et al.  Trends in the Prevalence, Awareness, Treatment, and Control of Hypertension Among Young Adults in the United States, 1999 to 2014 , 2017, Hypertension.

[27]  M. Fornage,et al.  Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association , 2017, Circulation.

[28]  David M. Lunderberg,et al.  Fluorinated Compounds in U.S. Fast Food Packaging. , 2017, Environmental science & technology letters.

[29]  Jun Huang,et al.  Occurrence and source apportionment of Per- and poly-fluorinated compounds (PFCs) in North Canal Basin, Beijing , 2016, Scientific Reports.

[30]  K. Christensen,et al.  Perfluoroalkyl substances in older male anglers in Wisconsin. , 2016, Environment international.

[31]  M. Bloom,et al.  Perfluoroalkyl substances and thyroid function in older adults. , 2015, Environment international.

[32]  K. Steenland,et al.  Modeled PFOA Exposure and Coronary Artery Disease, Hypertension, and High Cholesterol in Community and Worker Cohorts , 2014, Environmental health perspectives.

[33]  John R. Bucher,et al.  Systematic Review and Evidence Integration for Literature-Based Environmental Health Science Assessments , 2014, Environmental health perspectives.

[34]  C. Lau,et al.  Elevated blood pressure in offspring of rats exposed to diverse chemicals during pregnancy. , 2014, Toxicological sciences : an official journal of the Society of Toxicology.

[35]  A. Shankar,et al.  No association between perfluoroalkyl chemicals and hypertension in children , 2014, Integrated blood pressure control.

[36]  Qingyu Huang,et al.  Perfluorooctanoic acid induces apoptosis through the p53-dependent mitochondrial pathway in human hepatic cells: a proteomic study. , 2013, Toxicology letters.

[37]  Merlin C. Thomas,et al.  Does a Nephron Deficit Exacerbate the Renal and Cardiovascular Effects of Obesity? , 2013, PloS one.

[38]  Alan D. Lopez,et al.  A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 , 2012, The Lancet.

[39]  A. Shankar,et al.  Perfluorooctanoic acid and cardiovascular disease in US adults. , 2012, Archives of internal medicine.

[40]  J. Min,et al.  Perfluorooctanoic acid exposure is associated with elevated homocysteine and hypertension in US adults , 2012, Occupational and Environmental Medicine.

[41]  M. V. van Erk,et al.  Perfluoroalkyl sulfonates cause alkyl chain length-dependent hepatic steatosis and hypolipidemia mainly by impairing lipoprotein production in APOE*3-Leiden CETP mice. , 2011, Toxicological sciences : an official journal of the Society of Toxicology.

[42]  D. Melzer,et al.  Association between Serum Perfluorooctanoic Acid (PFOA) and Thyroid Disease in the U.S. National Health and Nutrition Examination Survey , 2010, Environmental health perspectives.

[43]  T. Webster,et al.  Exposure to Polyfluoroalkyl Chemicals and Cholesterol, Body Weight, and Insulin Resistance in the General U.S. Population , 2009, Environmental health perspectives.

[44]  D. Moher,et al.  Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement , 2009, BMJ : British Medical Journal.

[45]  R. Luebke,et al.  Immunotoxicity of Perfluorooctanoic Acid and Perfluorooctane Sulfonate and the Role of Peroxisome Proliferator-Activated Receptor Alpha , 2009, Critical reviews in toxicology.

[46]  A. Calafat,et al.  Polyfluoroalkyl Chemicals in the U.S. Population: Data from the National Health and Nutrition Examination Survey (NHANES) 2003–2004 and Comparisons with NHANES 1999–2000 , 2007, Environmental health perspectives.

[47]  John W. Froehlich,et al.  Half-Life of Serum Elimination of Perfluorooctanesulfonate,Perfluorohexanesulfonate, and Perfluorooctanoate in Retired Fluorochemical Production Workers , 2007, Environmental health perspectives.

[48]  J. Higgins,et al.  Tools for assessing quality and susceptibility to bias in observational studies in epidemiology: a systematic review and annotated bibliography. , 2007, International journal of epidemiology.

[49]  Derek C G Muir,et al.  Biological monitoring of polyfluoroalkyl substances: A review. , 2006, Environmental science & technology.

[50]  Xiaofeng Yao,et al.  Genotoxic risk and oxidative DNA damage in HepG2 cells exposed to perfluorooctanoic acid. , 2005, Mutation research.

[51]  D. Altman,et al.  Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.

[52]  D. Grandér,et al.  Reactive oxygen species and mitochondria mediate the induction of apoptosis in human hepatoma HepG2 cells by the rodent peroxisome proliferator and hepatocarcinogen, perfluorooctanoic acid. , 2001, Toxicology and applied pharmacology.

[53]  G. Smith,et al.  Bias in meta-analysis detected by a simple, graphical test , 1997, BMJ.

[54]  Manning Feinleib,et al.  Obesity as an Independent Risk Factor for Cardiovascular Disease: A 26‐year Follow‐up of Participants in the Framingham Heart Study , 1983, Circulation.

[55]  G. Jiang,et al.  Perfluorohexadecanoic acid increases paracellular permeability in endothelial cells through the activation of plasma kallikrein-kinin system. , 2018, Chemosphere.

[56]  A. Rule,et al.  The Substantial Loss of Nephrons in Healthy Human Kidneys with Aging. , 2017, Journal of the American Society of Nephrology : JASN.

[57]  A. Brem,et al.  Insights Into Glucocorticoid-Associated Hypertension. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.